open access
Expert opinion on adjuvant treatment with osimertinib in patients with non-small cell lung carcinoma after radical tumor resection
Affiliations- Department of Pathology, National Research Institute of Tuberculosis and Lung Diseases, Warsaw, Poland
- Department of Lung Cancer and Thoracic Tumours, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
- Department of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw, Poland
- Department of Surgery, National Research Institute of Tuberculosis and Lung Diseases, Warsaw, Poland
- Department of Thoracic Surgery, Medical University of Gdańsk, Poland
- Chair and Department of Biology and Medical Genetics, Medical University of Gdańsk, Poland
- Laboratory of Clinical Genetics, University Clinical Centre, Gdańsk, Poland
open access
Abstract
Abstract
About this articleTitle
Expert opinion on adjuvant treatment with osimertinib in patients with non-small cell lung carcinoma after radical tumor resection
Journal
Nowotwory. Journal of Oncology
Issue
Article type
Guidelines / Expert consensus
Pages
187-197
Published online
2023-06-27
Page views
1158
Article views/downloads
273
DOI
Bibliographic record
Nowotwory. Journal of Oncology 2023;73(3):187-197.
Authors
Renata Langfort
Maciej Krzakowski
Dariusz M. Kowalski
Rafał Krenke
Tadeusz Orłowski
Witold Rzyman
Bartosz Wasąg